🔎 Trials Near Me

Home › Cardiovascular Disease › NCT06870591

Pivotal Study for the Cardiac Performance System (CPS)

RecruitingObservational study

Pivotal Method-Comparison Study for the Cardiac Performance System (CPS) to Measure Hemodynamic Parameters

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Scheduled for clinically indicated right heart catheterization
* Ability to provide informed consent

Exclusion Criteria:

* Heart transplant recipients
* Patients with a left ventricular assist device (LVAD)
* Presence of external devices (e.g., Holter monitors) or surgical scars/wounds that interfere with CPS measurements
* Measurement concerns related to data reliability or quality

About the study

This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measurements to assess agreement and potential clinical utility.

What is being tested

Sponsor: Sensydia Corporation · Participants: 1,000 · Started: Apr 22, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06870591

Locations in the U.S.

AlabamaHuntsville Hospital Heart Center, Huntsville
IllinoisEndeavor Health, Evanston
New JerseyHackensack University Medical Center, Hackensack
Jersey Shore University Medical Center, Neptune City
New YorkColumbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
OhioThe Ohio State University Medical Center, Columbus
PennsylvaniaUniversity of Pennsylvania - Penn Presbyterian Medical Center, Philadelphia
South CarolinaMedical University of South Carolina, Charleston
TennesseeThe Stern Cardiovascular Foundation, Inc. / Baptist Memorial Hospital, Germantown
TexasBaylor College of Medicine, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.